Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro KwikPen prices in the UK private market typically range from around £149 to £375 per month, depending on the dose and the provider — a range that widened significantly after Eli Lilly raised the list price of higher doses from September 2025. Each pen is a once-weekly injection covering four doses; you pay per pen, not per injection. These are prescription-only medicines: a prescriber must assess your suitability before a pharmacy can dispense them, so any quote you see always has a clinical process behind it. At nume, that process is free, runs the same day, and is reviewed by a GPhC-registered Independent Prescriber — not automated software.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer: the list price of the pen changed sharply, and providers have passed that through differently. Eli Lilly raised the UK list price of the higher-strength Mounjaro pens from around £122 to around £330 per four-week pen from 1 September 2025, as widely reported at the time. That single move compressed margins at the lower end of the market and pushed private prices upward across most doses.
Dose matters too. A 2.5mg starter pen costs considerably less than a 12.5mg or 15mg maintenance pen. Treatment normally begins at the lower dose and is titrated upward by the prescriber every four weeks or so, which means your monthly spend will rise over the first few months if everything is going well clinically. If you want to understand how the Mounjaro price shifts as you move through each dose, the titration schedule is explained in more detail alongside the figures. The full picture of how Mounjaro works explains the titration schedule in more detail.
The other variable is what each provider actually includes. A headline price from one service may cover the pen only; another might roll in consultation, prescription and delivery. That gap matters when you are comparing. If you want a closer look at how dose-specific pricing breaks down, the Mounjaro pen prices overview covers each strength in context.
This is the bit that catches people out. A quoted per-pen figure sometimes excludes the consultation fee charged before the first prescription, a separate prescription-issuance charge, delivery (often £5–£10 per order elsewhere), and any ongoing clinical review costs when you request a repeat or a dose increase. Add those up across several months of treatment and the gap between a seemingly cheap option and an all-in one can shrink fast. It adds up.
At nume... sorry, at our consultation page, none of those charges exist separately. The price you see for the treatment covers everything: the consultation your prescriber conducts, the prescription they issue, the KwikPen itself, and the DPD delivery that arrives the next working day. Order before 12pm and your prescription is reviewed that afternoon, useful if you want it on the doorstep before the weekend without staying in all day waiting.
For a dose-specific breakdown, the 5mg KwikPen price page gives a worked example of what changes as treatment progresses.
No, and that is a deliberate choice. Cheapest is not a race we entered. Our single transparent price covers everything listed above; a provider trimming that price is usually trimming something else too, whether that is the clinical review, the aftercare, or the speed of access.
What we do offer: a clinical team that personally reviews every consultation the same day, identity verification, live weight confirmation on video, GP notification in line with GPhC guidance, and a clinical check before every single repeat order. There are no auto-renewals pulling money from your account. Every order is a fresh clinical decision. If you want to see how the overall Mounjaro pen price is structured without any calculation required, the Mounjaro pricing page shows it plainly.
The weight-loss treatment overview also compares Mounjaro against other licensed options if you are still deciding which medicine suits your situation.
The MHRA has warned repeatedly about fake weight-loss pens sold online, including counterfeit tirzepatide pens seized from an illicit manufacturing site in Northampton in October 2025, alongside roughly 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million. Some counterfeit pens have contained insulin. The common thread in nearly every case: the product was offered without a valid prescription, through an unverified seller, often at a price well below the market.
For a Prescription-Only Medicine (which Mounjaro is) the right questions are: is the pharmacy registered with the GPhC, is a qualified prescriber genuinely reviewing your case, and is the supply chain licensed? You can verify any online pharmacy directly at the GPhC pharmacy register; nume's registration number is 9012878. A small saving on the pen price is not worth the risk of an unverified product. NICE's appraisal of tirzepatide (TA1026) sets out the clinical context for this medicine; reading it makes clear why proper oversight matters.
Questions about the process? The FAQs cover the most common ones, or you can contact the team directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.